UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2015, ISBN 9781439910245, viii, 219
Book
1995, Medical ethics series, ISBN 9780253326195, 193
Book
1995, ISBN 0309053293, xi, 334
Book
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 2014, Volume 71, Issue 6, pp. 681 - 688
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Excitatory Amino Acid Antagonists - therapeutic use | Double-Blind Method | Humans | Middle Aged | Excitatory Amino Acid Antagonists - administration & dosage | Male | Ketamine - administration & dosage | Stress Disorders, Post-Traumatic - complications | Cross-Over Studies | Depression - drug therapy | Administration, Intravenous | Ketamine - adverse effects | Psychiatric Status Rating Scales | Stress Disorders, Post-Traumatic - drug therapy | Midazolam - therapeutic use | Adult | Depression - complications | Female | Ketamine - therapeutic use | Anti-Anxiety Agents - therapeutic use | Chronic Disease | Excitatory Amino Acid Antagonists - adverse effects | Depressive Disorders | Intrusive Thoughts | Comorbidity | Americans | Survivors | Hallucinogenic Drugs | Longitudinal Study | PTSD (DSM-IV) | Benzodiazepines | Randomized Clinical Trial | Treatment Effectiveness | Psychopharmacology | Arousal | Adults | Dissociative Symptoms | Negative Therapeutic Reaction | Stressors | Avoidance | Biologic Markers
Journal Article
British journal of psychiatry, ISSN 0007-1250, 02/2003, Volume 182, Issue 2, pp. 135 - 140
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Borderline Personality Disorder - psychology | Borderline Personality Disorder - drug therapy | Humans | Middle Aged | Self-Injurious Behavior - prevention & control | Treatment Outcome | Combined Modality Therapy | Suicide, Attempted - prevention & control | Psychiatric Status Rating Scales | Antipsychotic Agents - therapeutic use | Adult | Female | Aged | Borderline Personality Disorder - therapy | Patient Compliance | Behavior Therapy - methods | Therapy | Self injury | High risk | Substance abuse treatment | Risk behavior | Referrals | Mental health | Behaviour therapy | Psychotherapy | Retention | Addictive behaviors | Suicides & suicide attempts | Patient satisfaction | Personality disorders | Supervision | Women | Impulsivity | Efficacy | Personality | Behavior modification | Mutilation | Psychologists | Addictions | Patients | Psychiatric services | Addiction | Therapists | Borderline personality disorder | Index Medicus
Journal Article
American family physician, ISSN 0002-838X, 03/2018, Volume 97, Issue 5, pp. 313 - 320
Medicine, General & Internal | Primary Health Care | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Buprenorphine | Dosage and administration | Dopamine | Mental disorders | Pathophysiology | Narcotics | Physicians | Drug withdrawal | Methadone | Addictions | Patients | Primary care | Pain | Drug dosages | Drug use | Supervision | Index Medicus | Abridged Index Medicus
Journal Article
Drug safety, ISSN 0114-5916, 2009, Volume 32, Issue 1, pp. 1 - 18
Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Phosphodiesterase Inhibitors - therapeutic use | Vision Disorders - physiopathology | Phosphodiesterase Inhibitors - adverse effects | Adverse Drug Reaction Reporting Systems | Erectile Dysfunction - drug therapy | Humans | Risk Factors | Phosphodiesterase 5 Inhibitors | Male | Clinical Trials as Topic | Vision Disorders - drug therapy | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 2014, Volume 311, Issue 16, pp. 1641 - 1651
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pseudotumor Cerebri - drug therapy | Pseudotumor Cerebri - diet therapy | Humans | Male | Treatment Outcome | Combined Modality Therapy | Vision Disorders - drug therapy | Weight Loss | Diet, Sodium-Restricted | Pseudotumor Cerebri - complications | Quality of Life | Adult | Female | Acetazolamide - therapeutic use | Carbonic Anhydrase Inhibitors - therapeutic use | Vision Disorders - etiology | Hypertension | Clinical trials | Inhibitor drugs | Medical treatment | Clinical outcomes
Journal Article
The journal of clinical psychiatry, ISSN 0160-6689, 2011, Volume 72, Issue 12, pp. 1651 - 1658
Psychology, Clinical | Social Sciences | Life Sciences & Biomedicine | Psychiatry | Psychology | Science & Technology | Vision disorders | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Depression | Medical sciences | Nervous system (semeiology, syndromes) | Neurology | Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes | Psychopathology. Psychiatry | Mood disorders | Ophthalmology | Behavior therapy. Cognitive therapy | Treatments | Severity of Illness Index | Single-Blind Method | Humans | Middle Aged | Sleep Initiation and Maintenance Disorders - therapy | Depressive Disorder, Treatment-Resistant - therapy | Male | Treatment Outcome | Combined Modality Therapy | Hypnotics and Sedatives - therapeutic use | Depressive Disorder, Treatment-Resistant - drug therapy | Antidepressive Agents - therapeutic use | Psychiatric Status Rating Scales | Time Factors | Adult | Female | Sleep Initiation and Maintenance Disorders - drug therapy | Behavior Therapy - methods | Index Medicus
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | Life Sciences & Biomedicine | Oncology | Science & Technology | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article